Goldstein Advisors’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
3,598
-93
-3% -$25.9K 0.1% 79
2026
Q1
$1.01M Sell
3,691
-79
-2% -$22.6K 0.11% 69
2025
Q4
$1.09M Sell
3,770
-58
-2% -$16.2K 0.12% 65
2025
Q3
$994K Sell
3,828
-341
-8% -$85.6K 0.12% 67
2025
Q2
$1.04M Buy
4,169
+22
+0.5% +$5.44K 0.14% 61
2025
Q1
$1.1M Sell
4,147
-178
-4% -$47.4K 0.16% 51
2024
Q4
$1.1M Buy
4,325
+56
+1% +$15.1K 0.16% 51
2024
Q3
$1.2M Sell
4,269
-23
-0.5% -$6.39K 0.18% 45
2024
Q2
$1.14M Sell
4,292
-55
-1% -$14.4K 0.19% 44
2024
Q1
$1.18M Sell
4,347
-5
-0.1% -$1.31K 0.2% 42
2023
Q4
$1.09M Sell
4,352
-179
-4% -$42.4K 0.18% 70
2023
Q3
$1.07M Sell
4,531
-284
-6% -$69.2K 0.22% 42
2023
Q2
$1.18M Sell
4,815
-12
-0.2% -$2.92K 0.25% 44
2023
Q1
$1.15M Buy
4,827
+237
+5% +$57K 0.25% 45
2022
Q4
$1.14M Buy
+4,590
New +$1.11M 0.28% 43

Other funds holding VHT

Goldstein Advisors's VHT Position: Q2 2026 in Review

Goldstein Advisors reduced its Vanguard Health Care ETF (VHT) stake by 2.5% in Q2 2026, selling an estimated $25.9K and leaving 3,598 shares worth $1.08M. The position accounts for 0.1% of the portfolio, ranked #79.

Goldstein Advisors first reported a position in VHT in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.2M in Q3 2024. 1,113 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Goldstein Advisors held 3,598 shares of Vanguard Health Care ETF worth $1.08M as of Q2 2026.
  • Goldstein Advisors sold 93 Vanguard Health Care ETF shares in Q2 2026, an estimated $25.9K.
  • Vanguard Health Care ETF made up 0.1% of Goldstein Advisors's portfolio in Q2 2026, its #79 holding.
  • Goldstein Advisors first reported a position in Vanguard Health Care ETF in Q4 2022 and has held it in 15 quarters since.
  • Goldstein Advisors's Vanguard Health Care ETF position peaked at $1.2M in Q3 2024.
  • 1,113 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Goldstein Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.